Harold Levy

Print

Harold Levy

Harold J. Levy, Co-President, Co-Chief Executive and Co-Chief Investment Officer, is responsible for the management of mid-capitalization value equity portfolios.  Previously, he worked over eleven years as a portfolio manager with Arnhold and S. Bleichroeder, Inc.  From 1983 to 1984, he was a research analyst with Lehman Brothers Kuhn Loeb.  In addition, from 1979 to 1983, he worked as a research analyst focusing on venture capital with E.M. Warburg, Pincus & Company.  Mr. Levy holds a B.A. in Economics from Wesleyan University (1975) and an M.B.A. from University of Chicago (1979).


Search
(ENZN) NASDAQ
Last Trade9.82
Change(%)price+0.01
Volume266286
News
  • 09-10-2009

    Enzon to Present at NewsMakers...

    Enzon to Present at NewsMakers in the Biotech Industry Conference

    click here for more information

  • 07-27-2009

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 07-27-2009

    Enzon to Present at BMO Focus...

    Enzon to Present at BMO Focus on Healthcare Conference

    click here for more information

  • 07-23-2009

    Enzon Enhances Governance with...

    Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

    click here for more information

  • 09-10-2009

    Enzon to Present at NewsMakers...

    Enzon to Present at NewsMakers in the Biotech Industry Conference

    click here for more information

  • 07-27-2009

    Enzon to Release Second Quarte...

    Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 05-14-2009

    UCB"s Cimzia® Approved in the...

    UCB"s Cimzia® Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
    -- Enzon to receive royalties for PEGylation technology--

    click here for more information

  • 12-08-2008

    Enzon Pharmaceuticals Commence...

    Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt

    click here for more information

  • 02-13-2009

    Enzon to Release Fourth Quarte...

    Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow

    click here for more information

  • 04-23-2008

    Cimzia®, Utilizing Enzon's PE...

    Cimzia®, Utilizing Enzon's PEGylation Technology, Approved in the U.S.

    click here for more information

  • 09-30-2008

    Enzon's New Oncaspar-IV™ Rec...

    Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
    -- Improved version to expand global potential --

    click here for more information

  • 07-31-2008

    Enzon Files For Spin-Off of Bi...

    Enzon Files For Spin-Off of Biotech Business

    click here for more information